Abstract
The compounds 4-chloro-N-methylamphetamine (CMA) and 4-chloro-amphetamine (4-CA) are probably depletors of 5-hydroxytryptamine (5-HT). This has been demonstrated as plausible in human subjects also. In rat brains, the 5-HT depleting potency of 4-CA exceeds that of CMA. In depressive patients, moreover, CMA behaves as an antidepressant. In view of these findings the following two hypotheses were tested.
-
1.
If there is any correlation between the 5-HT depleting potency of CMA and 4-CA on the one hand, and their antidepressant potency on the other, then the therapeutic potency of 4-CA must be expected to exceed that of CMA.
-
2.
In view of the hypothesis of Carlsson et al. (1969) that the motor activating effect of antidepressants is of largely noradrenergic determination, and their mood-improving effect largely serotonergic, the effect of CMA and 4-CA on motility can be expected to be small, and their effect on mood therefore more or less selective.
We found no unequivocal confirmation of these hypothesis. The possible causes of this failure are discussed, and avenues of further investigation are outlined.
Similar content being viewed by others
References
Bunney, W. E., Davis, J. M.: Norepinephrine in depressive reactions. Arch. gen. Psychiat. 13, 483 (1965).
Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effect of antidepressant drugs in the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-β-ethyl metatyramine. Europ. J. Pharmacol. 5, 357 (1969).
Coppen, A., Shaw, D. M., Farrell, J. P.: Potentiation of the antidepressive effects of a monoamine oxidase inhibitor by tryptophan. Lancet 1963 I, 79.
Frey, H. H.: p-Chloramphetamine similarities and dissimilarities to amphetamine. In: Amphetamine and related compounds. (E. Costa, and S. Garattini, ed.) New York: Raven Press 1970.
—, Magnussen, M. P.: Different central mediation of the stimulant effects of amphetamine and its p-chloro analogue. Biochem. Pharmacol. 17, 1299 (1968).
Fuller, R. W., Hines, C. W., Mills, J.: Lowering of brain serotonin level by chloramphetamines. Biochem. Pharmacol. 14, 483 (1965).
Glowinski, J., Axelrod, J.: Effect of drugs on the uptake, release and metabolism of H3-norepinephrine in the rat brain. J. Pharmacol. exp. Ther. 149, 43 (1965).
— —: Effect of drugs on the disposition of H3- norepinephrine in the rat brain. Pharmacol. Rev. 18, 775 (1966).
De Jonge, H.: Introduction to medical statistics. Proceedings of the Dutch Institute for Preventive Medicine, Leiden 1963.
Kaergaard Nielsen, C., Magnussen, M. P., Kampmann, E., Frey, H. H.: Pharmacological properties of racemic and optically active p-chloroamphetamine. Arch. int. Pharmacodyn. 170, 428 (1967).
Kits, T. P., Van Praag, H. M.: A controlled investigation of the antidepressive properties of p-chloro-N-methylamphetamine, a compound with selective influence on the metabolism of 5-hydroxytryptamine. Acta psychiat. scand. 46, 365 (1970).
Lapin, T. P., Oxenburg, J. F.: Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet 1969 I, 132.
Miller, F. P., Cox, R. H., Jr., Snodgrass, W. R., Maickel, R. P.: Comparative effects of p-chlorophenylalaline, p-chloroamphetamine and chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid. Biochem. Pharmacol. 19, 435 (1970).
Pletscher, A., Bartholini, G., Bruderer, H., Burkard, W. P., Gey, K. F.: Chlorinated arylalkylamines affecting the cerebral metabolism of 5-hydroxytryptamine. J. Pharmacol. exp. Ther. 145, 344 (1964).
— —, Prada, M. da: Metabolism of monoamines by blood platelets and relation to 5-hydroxytryptamine liberation. In: Mechanisms of release of biogenic amines, pp. 165–175. U. S. von Euler, S. Rosell and B. Uvnäs, ed. London: Pergamon Press 1966b.
—, Burkard, W. P., Bruderer, H., Gey, K. F.: Decrease of cerebral 5-hydroxytryptamine and 5-hydroxyindoleacetic acid by an arylalkylamine. Life Sci. 2, 828 (1963).
—, Prada, M. da, Burkard, W. P.: The effect of substituted phenylethylamines on the metabolism of biogenic amines. In: Amphetamines and related compounds. G. E. Costa and S. Garattini, ed. New York: Raven Press 1970.
— — —, Bartholini, G., Steiner, F. A., Bruderer, H., Bigler, F.: Aralkylamines with different effect on the metabolism of aromatic monoamines. J. Pharmacol. exp. Ther. 154, 64 (1966a).
Praag, H. M. van.: A critical investigation of the importance of monoamine oxidase inhibition and the therapeutic principle in the treatment of depression. Thesis, Utrecht 1962.
—: Antidepressants, catecholamines and 5-hydroxyindoles. Trends towards a more specific research in the field of antidepressants. Psychiat. Neurol. Neurochir. 70, 219 (1967).
—: Monoamines and depression. Reverse of the medal. Pharmacopsychiat. 2, 151 (1969).
—, Kits, T. P., Schut, T., Dijkstra, P.: An attempt at indirect evaluation of the noradrenaline hypothesis. Results of a pilot study of the antidepressive qualities of p-chloro-N-methylamphetamine. Behav. Neuropsychiat. 1, 57 (1969).
—, Korf, J., Woudenberg, F. van: Investigation into the possible influence of 4-chlorinated amphetamine derivatives and 5-hydroxytryptamine synthesis in man. Psychopharmacologia (Berl.) 18, 412 (1970).
— — —, Kits, T. P.: Influencing the human indoleamine metabolism by means of a chlorinated amphetamine derivative with antidepressive effect (p-chloro-N-methylamphetamine). Psychopharmacologia (Berl.) 13, 145 (1968).
—, Uleman, A. M., Spitz, J. C.: The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex. Psychiat. Neurol. Neurochir. 68, 329 (1965).
Sanders-Bush, E., Sulser, F.: On the mechanism of action of p-chloroamphetamine. Pharmacologist 11, 258 (1969).
— —: Biochemical consideration on the mode of action of p-chloroamphetamine. In: Amphetamines related compounds. (E. Costa and S. Garattini, ed.) New York: Raven Press 1970.
Schildkraut, J. J.: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Amer. J. Psychiat. 122, 509 (1965).
—: Tranylcypromine effects on norepinephrine metabolism in rat brain. Amer. J. Psychiat. 126, 925 (1970).
Verster, J., Praag, H. M. van: A comparative investigation of amphetamine and p-chloro-N-methylamphetamine in normal test persons. Pharmacopsychiat. 3, 239 (1970).
Author information
Authors and Affiliations
Additional information
This study was supported by grants from the Netherlands Organization for Pure Research (Z.W.O.).
Rights and permissions
About this article
Cite this article
van Praag, H.M., Schut, T., Bosma, E. et al. A comparative study of the therapeutic effects of some 4-chlorinated amphetamine derivatives in depressive patients. Psychopharmacologia 20, 66–76 (1971). https://doi.org/10.1007/BF00404060
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00404060